<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      Acute Rejection
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/acute-rejection" data-history-node-id="2979" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
        <p style="border:none; padding:0in">
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Acute Rejection
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
        </p>
       </div>
       <p>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 T cell mediated (Cellular Rejection)
                </span>
               </span>
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
         <ul>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Infiltration of the graft by
                  <b>
                   lymphocytes
                  </b>
                  and inflammatory cells
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Treatment: high dose steroids (methyl pred) is first line (~ 5 days
                  <u>
                   +)
                  </u>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
           <ul>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Thymoglobulin (polyclonal Ig anti-T cell)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Use depends on severity of rejection
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Indicated if Cr fails to improve after steroids
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    T cell subsets are measured before and during treatment until depleted
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Tacro target levels are
                    <b>
                     reset to ~8
                    </b>
                    if treated for acute T cell mediated rejection
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
           </ul>
          </li>
         </ul>
        </li>
       </ul>
       <p>
       </p>
       <p>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Antibody Mediated Rejection (ABMR)
                </span>
               </span>
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
         <ul>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Acute tissue injury with circulating donor-specific antibodies (DSAs); requires evidence of
                  <b>
                   antibody-mediated damage
                  </b>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
           <ul>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Igâ€™s deposit and activate complement: key is C4d staining in the graft will be strongly positive
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
           </ul>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Treatment:
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
           <ul>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    IV methyl prednisone (3-5 days)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Plasmapheresis
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li>
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <u>
                 <span style="font-size:12.0pt">
                  <span style="background:white">
                   <span style="font-family:Palatino">
                    <span style="color:black">
                     +
                    </span>
                   </span>
                  </span>
                 </span>
                </u>
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    IVIG
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
             <ul>
              <li>
               <span style="font-size:12.0pt">
                <span style="line-height:107%">
                 <span style="font-family:Palatino">
                  <span style="color:black">
                   Followed often by Rituxan before d/c
                  </span>
                 </span>
                </span>
               </span>
              </li>
             </ul>
            </li>
           </ul>
          </li>
         </ul>
        </li>
       </ul>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>